Tenax Therapeutics(TENX) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

TENX Tenax Therapeutics

Watchlist

6.5500
+0.0600+0.92%

Close Mar 31 16:00 ET

6.5500
0.00000.00%

Post 16:05 ET

26.01MMarket Cap-5.70P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswireMar 31 08:00 ET
Tenax Therapeutics | 10-K: FY2024 Annual Report
SECMar 25 16:16 ET · Announcements
Tenax Therapeutics | 8-K: Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
SECMar 25 16:10 ET · Announcements
Express News | Tenax Therapeutics Q4 2024 GAAP EPS $(0.18) Beats $(0.42) Estimate
BenzingaMar 25 16:09 ET
Tenax Therapeutics Completed Private Placements With Proceeds of About $125 M to Support Studies for TNX-103, Fund Ops Through 2027 >TENX
Dow JonesMar 25 16:09 ET
Express News | Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
ReutersMar 25 16:05 ET

Comments

Teddy123

Mar 26 15:00

Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

$Tenax Therapeutics (TENX.US)$
Tenax Raises Massive $125M War Chest: Phase 3 Heart Failure Drug Trial Gets Major Boost

Trytosaveabit

Mar 5 21:49

News! That’s one way to beat the hell outa good news! Hehehe

$Tenax Therapeutics (TENX.US)$ Reuters· just
Tenax Therapeutics Announces $25 Million Private Placement

Teddy123

Mar 5 21:49

Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF

$Tenax Therapeutics (TENX.US)$
Tenax Secures FDA Green Light for Dual Phase 3 Trials in Untreated Heart Condition

Jaguar8

Mar 5 21:47

NEWS

$Tenax Therapeutics (TENX.US)$
Tenax Therapeutics Announces $25 Million Private Placement
Wednesday, 5th March at 8:47 am
CHAPEL HILL, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ: TENX) (the "Company" or "Tenax Therapeutics"), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that it has entered into a securities purchase agreement for a private placement financing with RTW Inve...

Trytosaveabit

Mar 5 21:47

News

$Tenax Therapeutics (TENX.US)$ Reuters· 2 mins ago
Tenax Therapeutics : Agreement by FDA to Initiate Second Global Phase 3 Study, Level-2, With First Patient Expected to Be Enrolled This Year

Market Insights

Symbol Mini Chart % Chg

Collegium Pharmaceutical

COLL

+0.47%

Unlock the Full List